ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CREO Creo Medical Group Plc

35.25
-0.50 (-1.40%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Creo Medical Group Plc LSE:CREO London Ordinary Share GB00BZ1BLL44 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -1.40% 35.25 35.00 35.50 35.75 35.25 35.75 197,799 10:14:20
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 27.17M -26.94M -0.0746 -4.73 127.34M
Creo Medical Group Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker CREO. The last closing price for Creo Medical was 35.75p. Over the last year, Creo Medical shares have traded in a share price range of 23.25p to 49.50p.

Creo Medical currently has 361,251,418 shares in issue. The market capitalisation of Creo Medical is £127.34 million. Creo Medical has a price to earnings ratio (PE ratio) of -4.73.

Creo Medical Share Discussion Threads

Showing 1126 to 1150 of 2400 messages
Chat Pages: Latest  48  47  46  45  44  43  42  41  40  39  38  37  Older
DateSubjectAuthorDiscuss
05/4/2018
10:09
Hitting new highs again.
someuwin
20/3/2018
17:42
A confident and reassuringly positive update on current progress. The product is clearly a game-changer, but as I read it there will be no cash coming through the door for at least another 12-18 months. After that this could be quite an earner. Happy to stick around and see how it pans out - and indeed to top up on the inevitable drops in the share price
lurki0
20/3/2018
11:27
I guess the pullback today is because there was no blockbuster news about contracts or juicy new info about products? Or that full product rollout is not until 2019 maybe. I'm holding, this seems to be well run and on track, much better than some other AIM companies!
dplewis1
09/3/2018
12:29
Difficult to get hold of meaningful amounts.

I am surmising that the positive interest here is connected with an expectation of good news from the US re a ramping up of a Speedboat RS2 launch.

lurki0
09/3/2018
08:20
More buyers than sellers..
dplewis1
08/3/2018
13:30
wot is going on here?
gersemi
08/3/2018
13:07
Blimey on an absolute tear now
dplewis1
08/3/2018
10:33
Certainly sounds like there's massive potential here...

Craig Gulliford, Chief Executive Officer of Creo Medical, commented: "We are excited by today's announcement as it provides further validation of our technology. It is incredible that these patients were conscious, talking to the endoscopist and able to watch the procedure live on screen. While we need to collect additional supportive clinical data, we are encouraged by the results we've seen to date. We believe that procedures like this have the potential to eliminate the need for subsequent bowel surgery, with the obvious patient benefits aligned with material advantages to the healthcare system in terms of cost and patient safety."

someuwin
08/3/2018
09:11
Very perky. Let's hope these buys are "well-timed".
lurki0
08/3/2018
08:28
When I bought these a few months ago I had them down as a slow burner, it's now one of my best performers!
dplewis1
08/3/2018
08:23
Can't even buy £2k online.
someuwin
07/3/2018
17:18
Buy above the ask just before the close, really not many of these about!
dplewis1
07/3/2018
14:27
Tightly held, you see. That's what's causing the spikes. Could well be some sort of leak. Fascinating to see how this pans out in the short term.
lurki0
05/3/2018
15:03
Over a quid..leaky leaky
dplewis1
05/3/2018
14:56
Ticks up on almost every buy.
someuwin
05/3/2018
09:24
This has gone up in a straight line since the end of Feb, but only a few percent a day so it stays under the radar. Feels like it won't be too long before the suspense is lifted and we find out some good news..
dplewis1
02/3/2018
14:28
Just such low volumes though. If it's a leak they aren't exactly going to make millions off the back of it! Not that I'm complaining I picked up mine in the low 70's, but I think this is just PIs picking up a few off the back of CREO being at the Growth and Innovation forum a few weeks back
dplewis1
02/3/2018
11:21
Got a few of these on the back burner. Rather abruptly I find myself in profit! That's quite a spike over the last few days, which leads me to wonder whether it's a)positioning before the interims at the end of March, or b)there's good news in the pipeline.

Any ideas, anyone?

lurki0
01/3/2018
21:15
And long may it continue!
sh0wmethemoney
27/2/2018
12:39
Ticking up slowly but surely here over the past couple of months..
dplewis1
09/2/2018
08:26
Seems like a sensible approach. I guess as people get older and fatter there will be much more need for GI surgery and this CROMA method seems to be the safest of the lot.
dplewis1
08/2/2018
22:20
Yeh, have a few tucked away in the Sipp so hoping that in the net 15-20 years they are worth a good bit more than today ?
sh0wmethemoney
08/2/2018
11:11
Doesn't take much to shift this does it! Anyone else following? They are quite sparing with the updates but looks to be going in the right direction..
dplewis1
29/11/2017
10:14
RNS Number : 7877X
Creo Medical Group PLC
29 November 2017

Speedboat RS2 advances beyond initial pilot centre

Speedboat RS2 utilised at second NHS site

Chepstow, South Wales - 29 November 2017 - Creo Medical Group plc (AIM: CREO) is pleased to announce that Speedboat RS2 has been used by a second Gastroenterologist at a second NHS site to treat further patients. This follows the announcement earlier this year with the first patient being treated at St Marks hospital in London.

Initial feedback from the first two cases at this site confirmed the removal of lesions under local anaesthetic with a procedure time of under one hour. The patients were discharged on the same day and are now under routine follow-up and monitoring. We await final histology results.

Craig Gulliford, Chief Executive Officer of Creo Medical, commented: "We are excited by today's announcement as it provides further validation of our technology. It is incredible that these patients were conscious, talking to the endoscopist and able to watch the procedure live on screen. While we need to collect additional supportive clinical data, we are encouraged by the results we've seen to date. We believe that procedures like this have the potential to eliminate the need for subsequent bowel surgery, with the obvious patient benefits aligned with material advantages to the healthcare system in terms of cost and patient safety."

pecuniarum copia
21/8/2017
10:02
Good news on on the FDA approval ahead of schedule, will open the door to a big market ahead of the plan. Let the good news continue!!!
sh0wmethemoney
Chat Pages: Latest  48  47  46  45  44  43  42  41  40  39  38  37  Older

Your Recent History

Delayed Upgrade Clock